BeStock  
Stocks › Biotechnology › SPTX

Seaport Therapeutics SPTX

US equityMarket cap rank #3190Biotechnology
$18.05 −$0.27 (-1.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.05 0.00%
Open$18.02
Prev close$18.32
Day range$17.41 – $18.83
Volume284.3K
Market cap$966.23M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership104.7%+2.71 pts vs. prior quarter
Institutions holding74+13 vs. prior quarter
Insider trades (recent)20 buys / 1 sellsNet buying
Short interest6.97% of floatDays to cover 17.4 · as of 30 Oct 2026
Short-sale volume share24.1%5-day average of daily volume

Short-sale volume as % of daily volume

12%23%34%46%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$588.9K (13 inflow days, 7 outflow days).

Net flow by order size, last 20 sessions

+$638.2KSuper−$49.4KBig−$7,677Mid+$1.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 64.8% of shares outstanding.

Largest holders

  • PureTech Health plc31.17%
  • Arch Venture Partners, L.P.11.76%
  • General Atlantic Service Company, L.P.11.40%
  • Sofinnova Investments, Inc.6.66%
  • Third Rock Ventures, LLC3.85%
  • Canada Pension Plan Investment Board3.69%
  • FMR3.43%
  • J.P. Morgan Asset Management, Inc.3.33%

By investor type

  • VC/PE Fund41.28%
  • Public Company33.50%
  • Mutual Fund22.10%
  • Individual/Insider4.59%
  • Government Pension Fund3.70%
  • Hedge Fund3.49%
  • Sovereign Wealth Fund0.64%
  • Private Company0.02%

Reported short interest has risen from 5.63% to 6.97% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +749,377 1.8%
FMR Mutual Fund 2026/Q3 +652,572 3.4%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +201,365 0.7%
PureTech Health plc Public Company 2026/Q3 +16,685,013 31.2%
Arch Venture Partners, L.P. VC/PE Fund 2026/Q3 +6,294,951 11.8%
General Atlantic Service Company, L.P. VC/PE Fund 2026/Q3 +6,101,582 11.4%
Sofinnova Investments, Inc. VC/PE Fund 2026/Q3 +3,564,871 6.7%
Third Rock Ventures, LLC VC/PE Fund 2026/Q3 +2,061,222 3.9%
Canada Pension Plan Investment Board Government Pension Fund 2026/Q3 +1,975,791 3.7%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +1,785,104 3.3%
Foresite Capital Management, LLC VC/PE Fund 2026/Q3 +1,779,521 3.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,308,604 2.4%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +1,194,858 2.2%
Daphne Zohar Individual/Insider 2026/Q3 +1,194,001 2.2%
FMR Mutual Fund 2026/Q3 +1,185,100 2.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Daphne Zohar Chief Executive Officer Other Disposition -100,000 – 1,094,001
2 Nov 2026 Denice Torres Lead Independent Non-Employee Director Open Market Acquisition +5,000 $19.87 18,406
21 Jun 2026 Robert Hombach Independent Director Open Market Acquisition +13,000 $18.14 13,000
3 May 2026 General Atlantic Service Company, L.P. Initial Statement of Beneficial +0 – 6,101,582
3 May 2026 Steven Paul Founder & Non-Employee Chair of the Board Derivative Exercise and Retained +67,031 – 863,031
3 May 2026 PureTech Health plc Derivative Exercise and Retained +16,382,534 – 16,685,013
3 May 2026 Antony Loebel Chief Medical Officer & President of Clinical Development Derivative Exercise and Retained +20,109 – 20,109
3 May 2026 Denice Torres Lead Independent Non-Employee Director Derivative Exercise and Retained +13,406 – 13,406
3 May 2026 Lana Gladstein General Counsel Derivative Exercise and Retained +33,515 – 33,515
3 May 2026 Lauren White Chief Financial Officer Derivative Exercise and Retained +6,702 – 6,702
3 May 2026 Michael Chen Co-Founder & CSO Derivative Exercise and Retained +3,351 – 3,351
29 Apr 2026 Sandra Peterson Independent Director Other Derivative Acquisition +12,258 $18.00 12,258
29 Apr 2026 Sandra Peterson Independent Director Initial Statement of Beneficial +0 – 89,300
29 Apr 2026 Sharon Mates Independent Director Other Derivative Acquisition +49,033 $18.00 49,033
29 Apr 2026 Steven Paul Founder & Non-Employee Chair of the Board Other Derivative Acquisition +1,003,450 $18.00 991,192
29 Apr 2026 Steven Paul Founder & Non-Employee Chair of the Board Initial Statement of Beneficial +0 – 1,674,753
29 Apr 2026 PureTech Health plc Initial Statement of Beneficial +0 – 302,479
29 Apr 2026 Daphne Zohar Chief Executive Officer Other Derivative Acquisition +1,758,599 $18.00 1,486,786
29 Apr 2026 Daphne Zohar Chief Executive Officer Initial Statement of Beneficial +0 – 2,765,557
29 Apr 2026 Robert Hombach Independent Director Other Derivative Acquisition +12,258 $18.00 12,258

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 3,733,388 7.0% 17.4
15 Oct 2026 3,718,915 6.9% 17.9
30 Sep 2026 3,649,879 6.8% 8.9
15 Sep 2026 3,148,881 5.9% 20.7
31 Aug 2026 3,152,409 5.9% 26.0
14 Aug 2026 3,012,877 5.6% 25.1

Discussion

No comments yet — be the first to weigh in on SPTX.

Sign in to join the discussion.

Scroll to Top